Replies to post #194 on Idenix Pharmaceuticals (IDIX)

[DewDiligence]

I considered Dr. Brown an asset to the firm, so this is bad news. Let’s hope this is a singular event and not a harbinger of the kind of executive turnover that has plagued some biotech companies.

[go seek]

Dr. Brown was a good speaker in conference calls.
A search of publications by both, it appears Dr. Mayers has published much more...

Dr. Mayers appears to be younger (based on career reads)